Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha and Isotretinoin in T-Cell Malignancies
NCT00038376Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 1990
- Primary completion
- Jun 2005
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa, isotretinoin in T-cell lymphoma, Hodgkin lymphoma (HL), mycosis fungoides (MF), sponsored by University of Texas MD Anderson Cancer Center. Started May 1990; status: completed.
02
Drugs
interferon alfaisotretinoin
03
Conditions
T-cell lymphomaHodgkin lymphoma (HL)mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT00038376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038376.